- HK$1.97bn
- HK$988.34m
- CNY768.90m
- 59
- 87
- 88
- 94
Annual balance sheet for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,702 | 2,412 | 1,388 | 1,595 | 1,687 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 172 | 139 | 407 | 285 | 264 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,086 | 2,593 | 1,946 | 2,032 | 2,094 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 721 | 628 | 959 | 933 | 922 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,284 | 3,915 | 4,989 | 5,152 | 5,161 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 138 | 104 | 168 | 149 | 177 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 175 | 123 | 1,044 | 1,108 | 1,190 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,108 | 3,792 | 3,945 | 4,044 | 3,971 |
| Total Liabilities & Shareholders' Equity | 5,284 | 3,915 | 4,989 | 5,152 | 5,161 |
| Total Common Shares Outstanding |